In 2016, cardiovascular medicines in the Philippines were valued at approximately 27.2 billion Philippine pesos. Cardiovascular diseases are the leading causes of death in the Philippines. In 2017, there were approximately 51 thousand deaths due to
Sales value of cardiovascular pharmaceuticals in the Philippines from 2007 to 2016 (in billion Philippine pesos)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Sales value of pharmaceuticals Philippines 2018-2024
- Basic Statistic Hydrochlorothiazide out of pocket cost U.S. 2004-2021
- Premium Statistic Market share corporations pharmaceutical sales value Philippines 2007-2016, by type
- Basic Statistic Alprazolam out of pocket cost in the U.S. 2004-2021
- Basic Statistic Number of fluticasone prescriptions in the U.S. 2004-2021
- Premium Statistic Esomeprazole out of pocket cost U.S. 2006-2021
- Basic Statistic Esomeprazole prescriptions number U.S. 2007-2021
- Basic Statistic Rosuvastatin out-of-pocket cost U.S. 2004-2021
- Premium Statistic Number of rosuvastatin prescriptions in the U.S. 2004-2021
- Premium Statistic Fluticasone out of pocket cost in the U.S. 2004-2021
About the region
9
- Premium Statistic Market share of licensed drugs pharmaceutical sales Philippines 2007-2016, by type
- Premium Statistic Average per capita household medical care expenditure Philippines 2012-2015, by type
- Premium Statistic Import value of pharmaceutical products Philippines 2011-2022
- Premium Statistic Major source of pharmaceutical products Philippines 2022, by import value
- Premium Statistic Import volume of medicaments Philippines 2018-2022
- Premium Statistic Export value of pharmaceutical products Philippines 2011-2022
- Premium Statistic Number of employees pharmaceutical manufacturing Philippines 2006 & 2012, by region
- Premium Statistic Production workers pharmaceutical manufacturing Philippines 2006 & 2012, by region
- Premium Statistic Number of pharmaceutical manufacturing companies Philippines 2006 & 2012, by region
Selected statistics
6
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
Other regions
10
- Premium Statistic Insulin human out of pocket price in the U.S. 2004-2020
- Basic Statistic Colombia's pharmaceutical market size 2011-2019, by drug category
- Premium Statistic Largest domestic pharma companies in Brazil 2015
- Basic Statistic Rate of return on biopharma R&D late stage pipeline 2013-2022
- Basic Statistic Pharmaceutical manufacturing gross value added (aGVA) in UK 2008-2021
- Premium Statistic Foreign-to-Canadian generic drug price ratios by OECD country as of 2018
- Basic Statistic Value of pharmaceutical sales in Germany 2003-2021
- Premium Statistic Leading orphan designations in the EU by indication 2015
- Premium Statistic Latin America: brand vs generic medication spend 2014-2018
- Basic Statistic Number of persons misusing select Rx drug types in U.S. 2017, by gender
Related statistics
10
- Premium Statistic GDP share of pharmaceutical sales Philippines 2018-2024
- Premium Statistic Major source countries of pharmaceutical products imports Philippines 2022
- Premium Statistic Market share of leading pharmaceutical companies Philippines 2016
- Premium Statistic Market share of leading domestic pharmaceutical companies Philippines 2016
- Premium Statistic Market share of leading multinational pharmaceutical companies Philippines 2016
- Premium Statistic Number of retail traders in the pharmaceutical industry Philippines 2012, by region
- Premium Statistic Number of traders in the pharmaceutical industry Philippines 2012, by type
- Premium Statistic Community based drug rehabilitation participants Philippines 2018
- Premium Statistic Seizure volume of select drugs Philippines 2021, by type
- Premium Statistic Share of licensed contractors issued Philippines 2019, by contract size
Further related statistics
8
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's ad spending 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- CVS Health's total assets 2005-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's ad spending 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- CVS Health's total assets 2005-2023
PCC. (June 8, 2020). Sales value of cardiovascular pharmaceuticals in the Philippines from 2007 to 2016 (in billion Philippine pesos) [Graph]. In Statista. Retrieved May 23, 2024, from https://www.statista.com/statistics/1196461/philippines-sales-value-of-cardiovascular-drugs/
PCC. "Sales value of cardiovascular pharmaceuticals in the Philippines from 2007 to 2016 (in billion Philippine pesos)." Chart. June 8, 2020. Statista. Accessed May 23, 2024. https://www.statista.com/statistics/1196461/philippines-sales-value-of-cardiovascular-drugs/
PCC. (2020). Sales value of cardiovascular pharmaceuticals in the Philippines from 2007 to 2016 (in billion Philippine pesos). Statista. Statista Inc.. Accessed: May 23, 2024. https://www.statista.com/statistics/1196461/philippines-sales-value-of-cardiovascular-drugs/
PCC. "Sales Value of Cardiovascular Pharmaceuticals in The Philippines from 2007 to 2016 (in Billion Philippine Pesos)." Statista, Statista Inc., 8 Jun 2020, https://www.statista.com/statistics/1196461/philippines-sales-value-of-cardiovascular-drugs/
PCC, Sales value of cardiovascular pharmaceuticals in the Philippines from 2007 to 2016 (in billion Philippine pesos) Statista, https://www.statista.com/statistics/1196461/philippines-sales-value-of-cardiovascular-drugs/ (last visited May 23, 2024)
Sales value of cardiovascular pharmaceuticals in the Philippines from 2007 to 2016 (in billion Philippine pesos) [Graph], PCC, June 8, 2020. [Online]. Available: https://www.statista.com/statistics/1196461/philippines-sales-value-of-cardiovascular-drugs/